It is the first antibiotic created in three decades and could help combat the global rise of one of the world's most common sexually transmitted infections (STIs). Gepotidacin, an antimicrobial approved for use in urinary tract infections, has been shown to control the Neisseria gonorrhoeae, the bacteria that causes gonorrhea. Last year, the World Health Organization (WHO) highlighted that the origin of gonorrhea is a priority pathogen for the scientific community, both due to its rapid spread and because it is capable of evading the antibiotic effects of first-line treatment with cephalosporins, macrolides (such as the famous azithromycin), and influenza. Last year alone, gonorrhea caused 82 million new cases in people between 15 and 49 years of age worldwide.